ARS Pharma board member Lowenthal resigns; CMO Tanimoto terminated without cause

ARS Pharmaceuticals, Inc.

Richard Lowenthal resigned from the Board effective July 15, 2026, as a condition for severance.
CMO Sarina Tanimoto ceased employment on July 15, 2026, under termination without cause.
Lowenthal receives $217,350 and Tanimoto $111,780 as prorated 2026 target bonus payments.
Severance and bonus payments conditioned on execution of release of claims.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.